Bicycle Therapeutics Plc ADR’s recent filing unveils that its Chief Financial Officer Young Alethia unloaded Company’s shares for reported $1724.0 on Apr 02 ’25. In the deal valued at $8.02 per share,215 shares were sold. As a result of this transaction, Young Alethia now holds 45,390 shares worth roughly $0.34 million.
Then, Skynner Michael sold 1,038 shares, generating $7,764 in total proceeds. Upon selling the shares at $7.48, the CHIEF TECHNOLOGY OFFICER now owns 121,870 shares.
Before that, Skynner Michael sold 814 shares. Bicycle Therapeutics Plc ADR shares valued at $6,528 were divested by the CHIEF TECHNOLOGY OFFICER at a price of $8.02 per share. As a result of the transaction, Skynner Michael now holds 122,908 shares, worth roughly $0.91 million.
Stephens initiated its Bicycle Therapeutics Plc ADR [BCYC] rating to an Equal-weight in a research note published on November 08, 2024; the price target was $25. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in early September with a ‘”an Outperform”‘ rating. B. Riley Securities also remained covering BCYC and has decreased its forecast on August 07, 2024 with a “Neutral” recommendation from previously “Buy” rating. B. Riley Securities revised its rating on September 11, 2023. It rated BCYC as “a Buy” which previously was an “a Neutral”.
Price Performance Review of BCYC
On Tuesday, Bicycle Therapeutics Plc ADR [NASDAQ:BCYC] saw its stock fall -18.32% to $7.40. Over the last five days, the stock has lost -9.87%. Bicycle Therapeutics Plc ADR shares have fallen nearly -47.14% since the year began. Nevertheless, the stocks have fallen -70.03% over the past one year. While a 52-week high of $28.67 was reached on 01/07/25, a 52-week low of $6.10 was recorded on 04/09/25. SMA at 50 days reached $8.84, while 200 days put it at $17.36.
Levels Of Support And Resistance For BCYC Stock
The 24-hour chart illustrates a support level at 6.83, which if violated will result in even more drops to 6.27. On the upside, there is a resistance level at 8.52. A further resistance level may holdings at 9.65. The Relative Strength Index (RSI) on the 14-day chart is 40.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.13%. Stochastics %K at 59.15% indicates the stock is a holding.
The most recent change occurred on August 31, 2022 when Cowen began covering the stock and recommended ‘”an Outperform”‘ rating .
